Compare ALX & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALX | IRMD |
|---|---|---|
| Founded | 1928 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | N/A | 2014 |
| Metric | ALX | IRMD |
|---|---|---|
| Price | $217.30 | $95.58 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $72.00 |
| AVG Volume (30 Days) | 59.3K | ★ 79.1K |
| Earning Date | 02-09-2026 | 02-12-2026 |
| Dividend Yield | ★ 8.22% | 0.71% |
| EPS Growth | N/A | ★ 13.00 |
| EPS | ★ 7.14 | 1.65 |
| Revenue | ★ $215,838,000.00 | $80,511,268.00 |
| Revenue This Year | N/A | $15.17 |
| Revenue Next Year | N/A | $10.15 |
| P/E Ratio | ★ $30.65 | $57.88 |
| Revenue Growth | N/A | ★ 12.91 |
| 52 Week Low | $184.76 | $47.48 |
| 52 Week High | $260.84 | $98.53 |
| Indicator | ALX | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 49.76 | 55.56 |
| Support Level | $213.00 | $90.92 |
| Resistance Level | $221.99 | $98.53 |
| Average True Range (ATR) | 4.39 | 2.19 |
| MACD | 0.47 | -0.55 |
| Stochastic Oscillator | 47.78 | 61.17 |
Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing and redeveloping its properties. It has six properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.